Cellectis jumps 14% on talks of sale to Pfizer By: CNBC.com News May 28, 2015 at 15:57 PM EDT Pfizer reportedly approached Cellectis with a deal that could value it at about $1.64 billion, the Financial Times reported. Read More >> Related Stocks: Cellectis S.A. ADR Pfizer